13 completed, 5 unknown, 1 recruiting. 11 Not applicable, 8 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 9, Unknown 2 |
| Phase 2 | 8 | Completed 4, Unknown 3, Recruiting 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Carnosine: new trials by email Literature Review of Carnosine trials Research Report on Carnosine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Carnosine In Patients With Peripheral Arterial Disease Patients Carnosine - Peripheral Arterial Disease | Phase 1 / Phase 2 | Recruiting | Shahid Baba | 144 | 2025-05-20 | 2025-05-29 |
| Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine, Placebo - Visceral Obesity, Non-alcoholic Fatty Liver | Not applicable | Completed | Fundació Eurecat | 50 | 2024-06-07 | 2025-04-17 |
| Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine, Placebo - Visceral Obesity, Non-Alcoholic Fatty Liver Disease | Not applicable | Completed | Fundació Eurecat | 20 | 2023-05-01 | 2024-02-23 |
| Carnosine for Peripheral Arterial Disease Patients Carnosine - Peripheral Arterial Disease | Phase 1 / Phase 2 | Unknown | Shahid Baba | 20 | 2023-03-01 | 2024-07-22 |
| Research on Prevention, Intervention and Mechanisms of Obesity and Its Comorbidities Complex lifestyle intervention, Carnosine - Obesity, Exercise | Not applicable | Unknown | Slovak Academy of Sciences | 60 | 2021-11-01 | 2022-01-27 |
| Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients Carnosine - Diabetic Neuropathies | Not applicable | Completed | Beni-Suef University | 60 | 2021-01-14 | 2022-06-29 |
| Oral Carnosine for Neuromuscular Performance in Multiple Sclerosis Carnosine, capsulle, 2 g/day, 8 weeks - Multiple Sclerosis | Not applicable | Completed | University of Novi Sad, Faculty of Sport and Physical Education | 3 | 2019-06-15 | 2020-03-24 |
| Carnosine for Peripheral Vascular Disease Carnosine, Placebo - Peripheral Arterial Disease | Phase 2 | Unknown | Monash University | 104 | 2019-03-01 | 2020-12-29 |
| Nucleophilic Defense Against PM Toxicity (NEAT Trial) L-carnosine, placebo - Air Pollution Toxicity | Not applicable | Completed | University of Louisville | 299 | 2018-04-01 | 2026-01-06 |
| The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk carnosine, Placebo - Insulin Sensitivity | Not applicable | Unknown | Monash University | 84 | 2017-02-13 | 2018-03-22 |
| The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health carnosine, Placebo - Poor Glycemic Control, Cardiovascular Risk Factors | Phase 2 | Unknown | Monash University | 40 | 2016-10-01 | 2022-06-28 |
| Carnosine for Peripheral Arterial Disease Carnosine, Placebo - Peripheral Arterial Disease | Phase 2 | Completed | University of Louisville | 10 | 2016-05-12 | 2022-08-04 |
| Carnosine and Cognitive Training in Schizophrenia L-Carnosine, Placebo, Cognitive Training - Schizophrenia | Phase 2 / Phase 3 | Completed | Abraham Reichenberg | 60 | 2015-12-01 | 2022-08-23 |
| Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes Carnosine, Placebo - Type 1 Diabetes, Oxidative Stress | Not applicable | Completed | Ain Shams University | 90 | 2015-08-01 | 2016-10-10 |
| L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients L-CARNOSINE - Peripheral Neuropathy, Cancer | Phase 1 / Phase 2 | Completed | Cairo University | 65 | 2015-06-01 | 2017-04-24 |
| Effect of Carnosine on Diabetes and Cardiovascular Risk Factors Carnosine - Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease | Not applicable | Completed | Jozef Ukropec | 28 | 2013-12-01 | 2018-04-17 |
| Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI) Carnosine, Placebo - Persian Gulf Syndrome | Phase 2 | Completed | Georgetown University | 33 | 2008-08-01 | 2019-06-28 |
| L-Carnosine for Bipolar I Disorder L-carnosine - Bipolar I Disorder | Not applicable | Completed | University of Pittsburgh | 47 | 2004-09-01 | 2016-01-11 |
| L-carnosine for Schizophrenia L-carnosine (dietary supplement) - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | University of Pittsburgh | 84 | 2004-03-01 | 2013-01-16 |
Diabetes Mellitus, Type 2 (4) · Peripheral Arterial Disease (4) · Cardiovascular Diseases (2) · Fatty Liver (2) · Motor Activity (2) · Non-alcoholic Fatty Liver Disease (2) · Obesity, Abdominal (2) · Psychotic Disorders (2) · Schizophrenia (2) · Diabetes Mellitus, Type 1 (1) · Diabetic Nephropathies (1) · Diabetic Neuropathies (1) · Fibromyalgia (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Hyperglycemia (1)
Monash University (3) · Fundació Eurecat (2) · Shahid Baba (2) · University of Louisville (2) · University of Pittsburgh (2) · Abraham Reichenberg (1) · Ain Shams University (1) · Beni-Suef University (1) · Cairo University (1) · Georgetown University (1) · Jozef Ukropec (1) · Slovak Academy of Sciences (1) · University of Novi Sad, Faculty of Sport and Physical Education (1)
United States (8) · Australia (3) · Egypt (2) · Slovakia (2) · Spain (2) · Serbia (1)
K.N. Roy Chengappa, MD (2) · Amr Shafik, Assoc. Prof (1) · Antoni Caimari, PhD (1) · Avi Reichenberg, PhD (1) · Barbara Ukropcova, MD, PhD (1) · Barbara Ukropcova, Prof. (1) · Boris Krahulec, MD, PhD (1) · H F Salem, Professor (1) · James N Baraniuk, MD (1) · Jozef Ukropec, PhD (1) · Mona Schaalan, assoc. prof. (1)
PMID 12473676, PMID 18616962, PMID 19276232, PMID 20097752, PMID 20925384, PMID 21160056, PMID 21887102, PMID 22020113, PMID 22271716, PMID 22608666, PMID 22852051, PMID 23099060, PMID 23559625, PMID 23618477, PMID 23670612, PMID 23899755, PMID 25287762, PMID 25821809, PMID 25908725, PMID 27780829, PMID 28864708, PMID 29277966, PMID 33372072, PMID 33986049, PMID 38004228, PMID 39215872, PMID 39599686, PMID 39770949, PMID 41767833, PMID 7664889, PMID 7867189
R01ES019217 (1), R01HL163419 (1)